A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

NCT07318558 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

900

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Neoplasms
Ovarian Cancer

Interventions

DRUG: Sacituzumab tirumotecan
DRUG: Bevacizumab
DRUG: Rescue Medications

Sponsor

Merck Sharp & Dohme LLC